The combination of modular facilities and closed processing offers significant advantages in the production of biopharmaceuticals and is becoming a compelling option for manufacturing.
JP Bornholdt
Advertisement
JP Bornholdt is director, SlateXpace Technical Operations at CRB.
Articles by JP Bornholdt
Advertisement
Latest Updated Articles
Advertisement
Advertisement